ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 98 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $412,243 | -9.3% | 85,884 | +41.9% | 0.00% | – |
| Q2 2023 | $454,423 | +341.8% | 60,509 | +165.9% | 0.00% | – |
| Q1 2023 | $102,853 | -45.7% | 22,755 | +35.4% | 0.00% | – |
| Q4 2022 | $189,336 | -36.9% | 16,800 | -46.5% | 0.00% | – |
| Q3 2022 | $300,000 | -46.8% | 31,400 | -54.9% | 0.00% | – |
| Q2 2022 | $564,000 | -62.7% | 69,693 | -22.1% | 0.00% | – |
| Q1 2022 | $1,512,000 | -53.8% | 89,512 | -41.2% | 0.00% | – |
| Q4 2021 | $3,274,000 | -42.2% | 152,340 | +98.5% | 0.00% | – |
| Q3 2021 | $5,669,000 | +106.6% | 76,752 | +53.0% | 0.00% | – |
| Q2 2021 | $2,744,000 | -38.4% | 50,161 | -17.0% | 0.00% | – |
| Q1 2021 | $4,457,000 | +61.7% | 60,450 | +89.1% | 0.00% | – |
| Q4 2020 | $2,756,000 | – | 31,964 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $716,436,000 | 71.38% |
| Logos Global Management LP | 3,156,981 | $233,175,000 | 16.81% |
| Vivo Capital, LLC | 4,220,048 | $311,693,000 | 14.00% |
| Cormorant Asset Management, LP | 1,012,079 | $74,752,000 | 3.04% |
| Redmile Group, LLC | 864,435 | $63,847,000 | 1.11% |
| Nan Fung Group Holdings Ltd | 41,950 | $3,098,000 | 0.99% |
| Artal Group S.A. | 500,000 | $36,930,000 | 0.83% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,706 | $9,506,000 | 0.80% |
| Pier Capital, LLC | 75,362 | $5,566,000 | 0.58% |
| Financial Advisory Group | 31,417 | $2,320,000 | 0.51% |